Kengo Sakaguchi Selected Research

Kengo Sakaguchi Research Topics

Disease

36	Neoplasms (Cancer) 01/2022 - 01/2002
6	Stomach Neoplasms (Stomach Cancer) 02/2005 - 02/2002
3	Neuroblastoma 05/2008 - 05/2004
1	Hypoxia (Hypoxemia) 01/2022
1	Malignant Mesothelioma 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Carcinoma (Carcinomatosis) 03/2019
1	Prostatic Neoplasms (Prostate Cancer) 06/2015
1	Rheumatoid Arthritis 01/2013
1	Autoimmune Diseases (Autoimmune Disease) 01/2013
1	Fanconi Anemia (Fanconi's Anemia) 11/2012
1	Warts (Wart) 05/2008
1	B-Cell Leukemia (Leukemia, B Cell) 05/2008
1	Necrosis 05/2008
1	Genomic Instability 01/2006
1	Inflammation (Inflammations) 05/2005

Drug/Important Bio-Agent (IBA)

7	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 09/2009 - 01/2003
6	DNA (Deoxyribonucleic Acid)IBA 11/2012 - 05/2005
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2005
3	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 02/2002
3	Radiation-Sensitizing AgentsIBA 01/2022 - 06/2015
3	Small Interfering RNA (siRNA)IBA 08/2012 - 02/2008
3	Type II DNA Topoisomerases (Topoisomerase II)IBA 05/2011 - 10/2003
3	epolactaeneIBA 05/2008 - 05/2004
3	dehydroaltenusinIBA 01/2007 - 02/2002
3	Pharmaceutical PreparationsIBA 01/2007 - 07/2005
3	GlycolipidsIBA 01/2007 - 07/2002
2	sulfoquinovosylacylpropanediolIBA 03/2019 - 06/2015
2	Cisplatin (Platino)FDA LinkGeneric 11/2012 - 07/2005
2	1- mono- O- acyl- 3- O- (alpha- D- sulfoquinovosyl)- glycerideIBA 08/2012 - 05/2008
2	CamptothecinIBA 12/2011 - 11/2005
2	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 12/2011 - 11/2005
2	Etoposide (VP 16)FDA LinkGeneric 05/2011 - 07/2005
2	DiglyceridesIBA 09/2009 - 10/2003
2	GemininIBA 03/2008 - 02/2008
2	DNA Polymerase I (Klenow Fragment)IBA 01/2007 - 05/2005
2	sulfoquinovosylacylglycerolIBA 01/2006 - 11/2005
2	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2006 - 10/2004
2	Immunosuppressive Agents (Immunosuppressants)IBA 10/2003 - 02/2003
2	sulfolipidsIBA 10/2003 - 01/2002
2	Fatty Acids (Saturated Fatty Acids)IBA 07/2002 - 01/2002
1	Messenger RNA (mRNA)IBA 01/2022
1	AsbestosIBA 01/2022
1	Thromboplastin (Tissue Factor)IBA 01/2022
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2021
1	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 12/2018
1	Gadolinium DTPA (Magnevist)FDA Link 12/2018
1	Oxyhemoglobins (Oxyhemoglobin)IBA 12/2018
1	Oxygen (Dioxygen)IBA 12/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2015
1	RoxithromycinIBA 01/2015
1	MacrolidesIBA 01/2015
1	Methotrexate (Mexate)FDA LinkGeneric 01/2013
1	Tetrahydrofolate Dehydrogenase (Dihydrofolate Reductase)IBA 01/2013
1	Thrombospondin 1IBA 08/2012
1	Biological ProductsIBA 12/2011
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 12/2011
1	pimonidazoleIBA 11/2010
1	CollagenIBA 11/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2008
1	coenzyme Q10 (CoQ10)IBA 02/2008
1	Angiogenesis InhibitorsIBA 02/2006
1	TocotrienolsIBA 01/2006
1	decaneIBA 01/2006
1	Ethanol (Ethyl Alcohol)IBA 01/2006
1	MicellesIBA 01/2006
1	AlkanesIBA 01/2006
1	EmulsionsIBA 01/2006
1	Nucleic Acid Synthesis InhibitorsIBA 11/2005
1	NK 109IBA 07/2005
1	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2005
1	Deoxyribonuclease I (Nickase)IBA 05/2005
1	EnzymesIBA 05/2005
1	trioctyl phosphine oxide (TOPO)IBA 05/2005
1	telomerase RNA (bTR)IBA 05/2005
1	PoisonsIBA 03/2005
1	Growth InhibitorsIBA 02/2005
1	Lipase (Acid Lipase)FDA Link 02/2005
1	dehydroebriconic acidIBA 04/2004
1	dehydrotrametenonic acidIBA 04/2004
1	Vitamin B 6IBA 12/2003
1	PyridoxalIBA 12/2003
1	PyridoxamineIBA 12/2003
1	Pyridoxine (Pyridoxin)FDA LinkGeneric 12/2003
1	CurcuminIBA 11/2003
1	petasiphenolIBA 11/2003
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 10/2003
1	MonoglyceridesIBA 10/2003
1	Ergosterol (Lumisterol)IBA 07/2003
1	VitaminsIBA 07/2003
1	7-dehydrocholesterolIBA 07/2003
1	Cholecalciferol (Vitamin D3)FDA Link 07/2003

Therapy/Procedure

4	Radiotherapy 01/2022 - 12/2018
2	Intravenous Injections 03/2019 - 12/2018
2	Drug Therapy (Chemotherapy) 01/2013 - 10/2003
2	Therapeutics 04/2011 - 01/2007
2	Transplantation 10/2003 - 02/2003
1	Radioimmunotherapy 01/2022
1	Intravenous Administration 03/2019
1	Injections 11/2010